Vaccination can also lower your chances of other serious shingles complications. For example, if it shows up on your face, ...

One in 50 pregnancies where the father is younger than 30 will have one of the common health conditions that are studied in ...

GSK's major growth drivers, Shingrix and Arexvy, along with recent legal progress, make its current undervaluation unjustified, leading to a "Strong Buy" rating. The company’s diversified ...

New study reveals potential cognitive benefits of Shingrix vaccine. The shingles shot may offer protection against dementia, especially in women.

I am a reasonably healthy 80-year-old man who is fortunate enough to have a partner of a child-bearing age. She would like to ...

As head of HHS, Kennedy would lead a sprawling federal department that encompasses more than 100 programs supporting medicine ...

I am a reasonably healthy 80-year-old man who is fortunate enough to have a partner of a child-bearing age. She would like to bear us a child. I ...

My fifth pillar of health is socialization. Make an effort to have a rich and full social life. There's an epidemic of ...

I am a reasonably healthy 80-year-old man who is fortunate enough to have a partner of a child-bearing age. She would like to bear us a child. I am concerned about any potential problems with my old ...

Shingrix grew 19% to £833 million in the quarter, backed up by solid performances for meningitis vaccines Bexsero and Menveo, which rose 34% to £218 million and 40% to £59 million, respectively.

Jefferies analyst Peter Welford downgraded GSK (GSK) to Hold from Buy with a price target of $39.50, down from $53. The firm ...

Q3 2024 Earnings Call Transcript November 7, 2024Dynavax Technologies Corporation beats earnings expectations.